BOSENTAN RAN bosentan (as monohydrate) 125 mg film-coated tablet blister pack

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

bosentan monohydrate, Quantity: 129.083 mg

Доступна с:

Sun Pharma ANZ Pty Ltd

ИНН (Международная Имя):

bosentan monohydrate

Фармацевтическая форма:

Tablet, film coated

состав:

Excipient Ingredients: pregelatinised maize starch; magnesium stearate; maize starch; povidone; sodium starch glycollate type A; glycerol dibehenate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose

Администрация маршрут:

Oral

Штук в упаковке:

56, 60

Тип рецепта:

(S4) Prescription Only Medicine

Терапевтические показания :

Bosentan is indicated for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including Eisenmenger?s physiology,in patients with WHO functional Class II, III or IV symptoms

Обзор продуктов:

Visual Identification: The 125mg film-coated tablets are light peach to peach colored, oval shaped, biconvex & debossed with '125' on one side & plain on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус Авторизация:

Licence status A

Дата Авторизация:

2016-07-11